News
2d
MedPage Today on MSNGLP-1 Med Users See Drop in Recurrent Afib EventsAnother benefit of GLP-1 receptor agonist (RA) use may be protection from persistent atrial fibrillation (Afib or AF) after ...
12h
US Weekly on MSNWellness Influencer Janelle Rohner Says She Is ‘Microdosing’ a GLP-1 to Lose WeightWellness influencer Janelle Rohner reveals she is 'microdosing' GLP-1 medication for weight loss and addresses criticism over ...
As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...
13h
US Weekly on MSNEverything Influencer Janelle Rohner Has Said About Weight Loss Before GLP-1 ControversyHealth and wellness influencer Janelle Rohner had been documenting her weight loss journey long before she admitted to using ...
Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...
GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...
Experts express alarm that GLP-1 RAs may trigger or worsen eating disorders. But is there any role they might play in binge ...
Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related ...
The rising use of GLP-1 agonists to help manage the obesity epidemic is not only reshaping how consumers taking the ...
Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...
Spending on Ozempic, Wegovy and other similar prescriptions soared 500 percent in five years, according to a research letter.
A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results